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"In the emplonnent setting, discrimina-
tion among individuals has long been legal-
ly, ethicalh-, and socially acceptable" (1 ). 
Employers may select prospective employees 
on the basis of their past experience or their 
education but are prohibited from selecting 
employees on the basis of specific categories 
such as age. color. and ethnic origin (1 ). 
Now there are numerous reasons for employ-
ers to expand the selection process to in-
clude genetic information. Employers are 
increasingly concerned about the spiraling 
cost of health insurance as well as the pos-
sibility of genetic susceptibility to illness 
caused by exposure to workplace toxins (2). 
The use of genetic information in the 
workplace roses societal risks that have an 
impact on emplO\·ment possibilities, health 
insurance, and rrivacy. Individuals who 
might otherwise believe that they can ben-
efit from genetic testing may decline it be-
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cause of thetr fear of employment discrimi-
nation and lack of privacy in the workplace 
(3). As a consequence, the future of re-
search on the benefits and risks of predic-
tive genetic testing may also be compro-
mised (4). Thus, policy-makers need to 
evaluate legislative and regulatory strategies 
to address these concerns. 
The Hereditary Susceptibility Working 
Group of the National Action Plan on 
Breast Cancer (NAPBC). coordinated by 
the PHS Office on Women's Health (5), 
recently joined with the National Institutes 
of Health-Department of Energy (NIH-
DOE) Working Group on Ethical, Legal and 
Social Implications of Human Genome Re-
search (the ELSI Working Group) (6) to 
address the issue of genetic information in 
the workplace. This commitment builds on 
their combined efforts to first address the use 
of, misuse of, and access to genetic informa-
tion in the health insurance context, and 
then to focus on these concerns in the work-
place. Obviously, the fears of discrimination 
in health insurance and employment are in-
tertwined. Without a job, most people in our 
country do not have health insurance. Yet 
genetic information in the workplace poses 
unique challenges. Employers in most juris-
dictions are not prohibited from requiring 
genetic testing, even though there is insuf-
ficient evidence to justify the use of any 
existing test for genetic susceptibility as a 
basis for employment decisions. Even if 
employers do not use genetic testing, they 
still may have access to the medical 
records of their employees and prospective 
employees, and thus will be able to find 
out if these individuals have cenain pre-
dispositions to disease. Employers may be 
reluctant to hire or promote individuals 
they believe will become prematurely un-
able to work (2). Thus, legislative and 
regulatory strategies to address discrimina-
tion and privacy concems in the work-
place should be considered along with the 
NAPBC and ELSI Working Group recom-
mendations on genetic information and 
health insurance that were promulgated 
and disseminated in 1995 (7, 8). 
Evolution of State Legislation 
The first law addressing genetic discrimina-
tion in the workplace was enacted in 1975 
when North Carolina passed legislation 
prohibiting employers from discriminating 
against any person possessing the traits for 
sickle cell or hemoglobin C (9). Over the 
next decade, four other states passed laws 
prohibiting employment discrimination 
based on the sickle cell trait, other specified 
traits, and carrier status (10). In 1989, Or-
egon added "genetic screening" to an exist-
ing law that made it unlawful for an em-
ployer to subject an employee or prospec-
tive employee to different types of tests, 
including breathalyzers and polygraphs 
( 11 ). Although this law did not include a 
definition for genetic screening, it was the 
first state law to go beyond specific traits 
and disorders. 
More comprehensive legislation emerged 
in 1991, when Wisconsin prohibited work-. 
place discrimination, prohibited employer 
access to genetic test results, and provided 
privacy protections for employees ( 12). This 
legislation addressed not only employers but 
also labor organizations, employment agen-
cies, and licensing agencies. The focus of the 
legislation was on genetic testing and not on 
the use of genetic information derived from 
phenotype indicators and family history. 
This Wisconsin legislation provides for ge-
netic testing of an employee if the employee 
requests the test. The law also requires writ-
ten and informed consent and specifies that 
no adverse action may be taken against the 
employee as a result of the test. This employ-
ee testing may only be conducted for the 
purpose of investigating a workers' compen-
sation claim or to determine the employee's 
susceptibility or level of exposure to toxic 
chemicals in- the workplace. Wisconsin's 
criminal code-specifically makes it unlawful 
to disclose genetic test information without 
the written and informed consent of the 
individual (13). 
Thus, the Wisconsin approach attempts 
to integrate protection against discrimina-
tion in employment with some privacy pro-
tection. Similar approaches have been in-
corporated to varying degrees in recent leg-
islation passed in Iowa (14), Rhode Island 
(15), New Hampshire (16), New York (17), 
and Oregon (18).This trend parallels simi-
lar state initiatives in the health insurance 
context (7, 8). 
In 1996, New Jersey enacted compre-
hensive legislation that prohibits employ-
ment discrimination based on genetic infor-
mation (19). Thus, New Jersey does not 
focus on genetic testing alone but expands 
the prohibition to include discrimination 
on the basis of "information about genes, 
gene products or inherited characteristics 
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that may deri,-e from an individual or fam-
ily member'' (19, 20). New Jersey also pro-
hibits retaliation by employers if an employ-
ee or prospecri,-e employee refuses to take a 
genetic test or reveal the results of a genetic 
test (19). 
In contrast. ~ew York law specifies that 
the emplo\·er rna\· '' ... require a specified 
genetic test as a condition of employment 
where such a test is shown to be directly 
related to the occupational environment, 
such that the emploYee or applicant with a 
particular genetic anomaly might be at an 
increased risk of disease as a result of work-
ing in said enYironment," but it is silent on 
the need for the written and informed con-
sent of the employee or applicant (17). 
Even when stare la\vs require informed con-
sent before genetic testing, they do not 
address whether the informed consent pro-
cess will pro\'ide notice that the test results 
may be disclosed without authorization un-
der certain circumstances, including pater-
nity, criminal proceedings, or health de-
partment protocols. 
Recent Federal Initiatives 
In 1995. the Equal Employment Opportu-
nity Commission \EEOC) issued a guidance 
in its comrliance manual on the definition 
of "disabilit\_., that addresses genetic dis-
crimination in the workplace. It stated that 
the Americans with Disabilities Act 
(ADA) would rrotect individuals subjected 
to discrimination on the "basis of genetic 
information relating to illness, disease or 
other disorders., ( 21 ) . To further clarify its 
position, it cites as an example an individ-
ual with a. positive predictive genetic test 
for colon cancer as being subject to protec-
tion under the ADA if the employer "re-
gards" the individual as having a disability 
and has discriminated against the individu-
al because of this perception. However, it is 
not clear whether this coverage will extend 
to unaffected individuals who are carriers of 
recessive or X-linked mutations. To date, 
there have been no genetic discrimination 
complaints filed with the EEOC, and the 
guidance has yet to be tested in court. Thus, 
in the absence of judicial decisions, the 
amount of protection actually provided by 
the ADA remains limited. 
Even though the ADA potentially offers 
protection from discrimination, the focus of 
the ADA is not the protection of an em-
ployee's privacy (22). Although the ADA 
does prevent employers from making pre-
employment medical inquiries, it does not 
prevent employers from obtaining medical 
information, including genetic information, 
after a conditional offer of employment. 
Employers can require a preplacement med-
ical exam, which may include a physical 
examination and blood tests (including ge-
netic tests). They may also require a general 
medical release of an individual's medical 
records. Although an employer is prohibit-
ed from discriminating on the basis of a 
disability, it is difficult for the individual to 
prove that he or she did not get a job or 
promotion, for example. because of disabil-
ity or other genetic information ( 1). 
In 1996, Congress passed the Health 
Insurance Portability and Accountability 
Act (23), which primarily applies to em-
ployer-based health insurance coverage and 
was designed to allow workers w maintain 
insurance coverage if they change or leave 
their jobs. It pertains w employers who 
provide health insurance coverage through 
self-funded plans as well as through insur-
ance companies, thus including those self-
funded plans that have been beyond the 
reach of state legislation because of the 
Employee Retirement Income Security Act 
(ERISA) preemption (24). 
The law specifically prohibits a group 
health insurance plan from using "genetic 
information" to establish rules for eligibil-
ity or continued eligibility. It also provides 
that genetic information shall not be 
treated as a "preexisting condition in the 
absence of the diagnosis of the condition 
related to such information" (.23). Howev-
er, the law does not provide any privacy 
protections. The burden would be on the 
employee to prove that the insurer did not 
use genetic information to deny coverage 
or affect the terms and conditions of 
health coverage. Furthermore. it does not 
prohibit group health plans from increas-
ing rates, excluding all coverage for a par-
ticular condition, or imposing lifetime 
caps on benefits as long as plan character-
istics are not "directed at individual sick 
employees or dependents" (23, 25). 
Policy Implications 
The development of public policy to ad-
dress genetic information in the workplace 
must be analyzed in light of the uncertainty 
about the future scope and impact of genet-
ic testing and the realities of the political 
process. It also must be placed in context 
with state and federal disability laws and 
other genetic discrimination and privacy 
legislation. 
The primary legislative approach to ad-
dressing genetic information in the work-
place is prohibition of employment discrim-
ination. Although some state laws prohibit 
employers from using the results of a chem-
ical test of DNA or the protein product of a 
gene, most of the laws do not expressly 
prohibit employers from using phenotype 
indicators, patterns of inheritance of genetic 
characteristics, or requests for genetic test-
ing as a basis for discrimination. Although 
some laws do attempt to prohibit both ac-
cess to and use of genenc test results, others 
provide for use of test results if the informa-
tion is job-related. At the present time, 
however, there is no scientific evidence to 
link unexpressed genetic factors and the 
ability to perform a job function. Therefore, 
employers cannot prove that the use of ge-
netic information is "job-related and consis-
tent with business necessity," the standard 
often applied in federal and state antidis-
crimination laws (26). Furthermore, some 
state laws provide for genetic testing by em-
ployers in order to determine an employee's 
susceptibility to toxic chemicals or substanc-
es in the workplace, even though cleaning 
up the environment would enhance the 
working conditions for all employees and 
would alleviate the need for genetic testing 
of individual employees (28). 
On the federal level, the ADA and the 
Health Insurance Portability and Account-
ability Act of 1996 appear to offer limited 
protection from discrimination but do not 
prohibit employers and insurers from gain-
ing access to genetic information. At 
present, there is no uniform protection 
against the use of, misuse of, and access to 
genetic information in the workplace. 
With these policy considerations in 
mind, the Hereditar\' Susceptibility Work-
ing Group of the NAPBC and the ELSI 
Working Group de,· eloped the following 
recommendations for state and federal pol-
icy-makers (26, 27). 
1) Employment organizations should be 
prohibited from using genetic information 
to affect the hiring of an individual or to 
affect the terms, conditions, privileges, ben-
efits, or termination of employment unless 
the employment organization can prove 
that this information is job related and 
consistent with business necessity. 
2) Employment organizations should be 
prohibited from requesting or requiring col-
lection or disclosure of genetic information 
prior to a conditional offer of employment, 
and under all other circumstances, employ-
ment organizations should be prohibited 
from requesting or requiring collection or 
disclosure of genetic information unless the 
employment organization can prove this in-
formation is job related and consistent with 
business necessity, or othenvise mandated 
by law. Written and informed consent 
should be required for each request, collec-
tion or disclosure. 
3) Employment organizations should be 
restricted from access to genetic informa-
tion contained in medical records released 
by individuals as a condition of empioy-
ment, in claims filed for reimbursement of 
health care costs, and other sources. 
4) Employment organizations should be 
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prohibited from releasing genetic informa-
tion without prior written authorization of 
the individual. Written authorization should 
be required for each disclosure and include to 
whom the disclosure will be made. 
5) Violators of these provisions should 
be subject to strong enforcement mecha-
nisms, including a private right of action. 
It is hoped that these recommendations 
will stimulate a comprehensive approach 
to addressing genetic privacy and discrim-
ination in the workplace. 
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